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ABSTRACT
Objective: To determine the pattern of occurrence of sarcomas afflicting the neck and
craniofacial region.
Design: A retrospective study (1982-1991).
Setting: Cancer Registry, Kenyatta National Hospital, Nairobi, Kenya.
Method: Examination was performed of the cancer records in the registry over the period
1982 to 1991 inclusive. Histopathological types of the sarcomas were then analysed to
indicate the numbers that occurred per year; and also the pattern of occurrence according
to age groups, gender and site.
Results: Of the 10,897 whole body neoplasms, 985 were sarcomas. Among these sarcomas,
160 (16%) were located in the neck and craniofacial region. The histopathological types of
the neoplasms included Kaposi’s sarcoma (39%), osteosarcoma (23%), rhabdomyosarcoma
(21 %), fibrosarcoma (13%), chondrosarcoma (two per cent), malignant fibrous
histiocytoma (one per cent) and dermatofibrosarcoma protuberans (one per cent).
Conclusion: The results of this investigation, in concordance with those of other series
worldwide, indicate that the various sarcomas afflicting the neck and craniofacial area are
generally rare.
INTRODUCTION
On a worldwide basis, reports on the patterns of
occurrence of sarcomas of the neck and craniofacial region
are limited to the presentations of specific case studies and
reviews. Yet these neoplasms comprise those malignancies
that often cause not only the most devastating morbidity
but also very rapid mortality among afflicted patients.
Sarcomas refer to a wide variety of rare malignant tumours
that arise from the primitive mesoderm including
connective tissue, endothelium, mesothelium and nerve
cell components. The poor prognosis of most patients with
a sarcoma of the head and neck region is due to its
aggressive behaviour, and difficulty in obtaining local
control(1).
So far, limited epidemiological studies have shown
little information causally linking environmental factors
to the occurrence of sarcomas in man. Furthermore, no
firm advances have been made towards the effective
treatment of nearly all these neoplasms for long-term
survival. The emergence of the human immunodeficiency
virus (HIV) infection has precipitated an increased
occurrence of Kaposi’s sarcoma of the neck and craniofacial
region. It is therefore important that baseline information
regarding the pattern of occurrence of these neoplasms is
reported frequently from all regions of the world. This
article presents the occurrence of various sarcomas of the
neck and craniofacial region over a ten-year period as
recorded at the Cancer Registry of the Kenyatta National
Hospital in Kenya.
MATERIALS AND METHODS
The Kenyatta National Hospital (KNH) in Nairobi, is
Kenya’s main medical teaching centre and referral hospital
serving a population of approximately 26 million. In 1968, a
cancer registry was established at the institution by the World
Health Organisation through the International Agency for
Research on Cancer(2).
The pathology records in the Cancer Registry at this centre
were examined for all cases of whole body malignant neoplasms,
whole body sarcomas and specifically neck and craniofacial
sarcomas occurring over the period 1982 to 1991 (10 years). The
neck and craniofacial sarcomas were then analysed to indicate
numbers occurring per year; and also according to age, sex and
site of occurrence.
RESULTS
Out of 10,897 whole body neoplasms, 985 were
sarcomas. Among the sarcomas afflicting the whole body
160 neck and craniofacial neoplasms were identified.
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Table 1
Yearly profile of whole body neoplasms and sarcomas
Year No. of whole body No. of whole body No. of neck and
neoplasms sarcomas craniofacial sarcomas
1982 1786 125 23
1983 1715 124 16
1984 1750 135 29
1985 1244 111 19
1986 939 77 15
1987 311 82 13
1988 733 69 14
1989 656 70 12
1990 856 90 9
1991 907 102 10
Total 10897 985 160
Table 2
Yearly profile of types of neck and craniofacial sarcomas
Year OS RMS FBS CHS MFH DFSP KS Yearly total
1982 7 1 2 0 0 1 12 23
1983 6 5 3 0 0 0 2 16
1984 8 7 7 2 0 0 5 29
1985 4 3 6 0 0 0 6 19
1986 3 5 2 0 0 0 5 15
1987 2 3 1 0 0 1 6 13
1988 5 3 0 0 0 0 6 14
1989 0 3 0 0 1 0 8 12
1990 1 1 0 1 0 0 6 9
1991 1 3 0 0 0 0 6 10
Total 37 34 21 3 1 2 62 160
Key:  OS=Osteorsarcoma; CHS=Chondrosarcoma; DFSP=Dermatofibrosarcoma protuberance; RMS=Rhaddomyosarcoma
MFH=Malignant fibrous histiocytoma; FBS=Fibrosarcoma; KS=Kaposi’s sarcoma
Table 3
Distribution of sarcoma types according to the age range and sex
Tumour type Age range (yrs) Sex distribution
0-10 11-20 21-30 31-40 41+ M F
KS 16 5 16 4 21 45 17
OS 4 12 9 3 9 21 16
RMS 22 9 - 1 2 18 16
FBS 5 3 1 2 10 16 5
CHS - 1 - 1 1 2 1
MFH - 1 - - - 1 -
DFSP - 1 - - 1 2 -
Total 47 32 26 11 44 105 55
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Table 4
Distribution of sarcomas of the neck and craniofacial region
according to site
Site No. of sarcomas %
Neck region 33 20.63









Temporal area 1 0.63
Scalp and calvarium 13 8.13
Total 160 100
Histopathologically, Kaposi’s sarcoma was the commonest
subtype (39%) followed by osteosarcoma (23%),
rhabdomyosarcoma (21%), fibrosarcoma (13%),
chondrosarcoma (two per cent), malignant fibrous
histiocytoma (one per cent) and dermatofibrosarcoma
protuberans (one per cent). Characteristics of the various
sarcoma types are presented in Tables 1-4.
DISCUSSION
Generally, neck and craniofacial mesenchymal malignant
neoplasms are rare. In the present study, these neoplasms
comprise only about 15% of all the sarcomas afflicting the
whole body. Remarkably, lesions occurring in the jaws
and floor of the mouth constituted more than 40% of all the
sarcomas afflicting the neck and craniofacial region. It is
also worthy of note in this series that most sarcomas
occurred in the youngest age group in the first decade of
life and the oldest age group above 40 years. In addition,
it is evident that males are afflicted more commonly than
females with an overall ratio of approximately 2:1.
As shown in Table 1, the yearly pattern of occurrence
of sarcomas in the neck and craniofacial region was
somewhat variable with a range of nine to 29 lesions. The
decreasing trend of the numbers of sarcomas diagnosed
after the mid 1980s may be attributed to the fact that other
centres than KNH within Nairobi and regionally had
started active participation in histopathological
examination and reporting. However, no specific reason
was apparent as to why the number of cases analysed in
1987 was exceptionally low.
Notably, the diagnosis of Kaposi’s sarcoma (KS)
occurring in the neck and craniofacial region generally
showed a consistent trend over the study period. This
neoplasm has been described as being one of the commonest
malignant tumours in Africa, accounting for about nine per
cent of all neoplasms in the indigenous population(3). The
neoplasm is the commonest cancer associated with the HIV
infection, occurring in up to one in four AIDS patients with
a male to female ratio of 20:1(4). Indeed, KS is now
epidemic in countries where HIV is most prevalent(5). The
present findings indicate a contrasting male to female ratio
of nearly 3:1 which may be a reflection of a regional
variation.
Among the soft tissue sarcomas, apart from KS,
rhabdomyosarcoma (RMS) was diagnosed most frequently
and our findings revealed a particularly high occurrence of
this neoplasm in the age group 0 to 10 years thereby
corroborating other published series. These neoplasms
have a relative predilection of the head and neck region(8).
RMS may be defined as a malignant tumour of the
rhabdomyoblasts and it is estimated to comprise 12% to
56% of all solid malignant tumours in the paediatric age
group(9).
Other malignant tumours of soft tissue origin included
the fibrosarcoma (FBS), malignant fibrous histocytoma
(MFH) and dermatofibrosarcoma protuberans (DFSP).
FBS is a malignant tumour whose occurrence in the head
and neck is rare, accounting for less than five per cent  of
fibrosarcomas of all sites(10). The intraoral or paraoral
FBS may arise in any location, but is most commonly
associated with the cheek, maxiliary sinus, pharynx, palate,
lip and periosteum of the maxilla or mandible(7). If
clinical data for children and young adults are combined,
FBS involving the head and neck make up 18% to 20% of
the cases(11). Among the paediatric cases, the
histopathology varies somewhat from that occurring in
adults and has a markedly different clinical behaviour(12).
The most striking finding in the present study was the male
to female ratio of about 3 to 1 of FBS occurring in the neck
and craniofacial region. Remarkably, five of the 21 cases
were children aged up to 10 years.
Over the ten-year period, only two cases of DFSP and
one of MFH had been diagnosed. DFSP is a rare
mesenchymal tumour of the skin whose incidence is low:
0.06% of all malignant neoplasms and 1.17% of all soft
tissue sarcomas(13). This neoplasm is said to be an
intermediate grade sarcoma that arises in the dermis of the
trunk, proximal extremities and less commonly in the head
and neck area of adults(14).
MFH is believed to be a rare tumour of the head and
neck(15). About three per cent of reported cases of MFH
have arisen in the head and neck(16). Although classically
defined as a soft tissue sarcoma, MFH can also originate
in bone(17). The most common and difficult problem in
the differential diagnosis is the distinction of MFH from
other malignant neoplasms showing a comparable degree
of cellular pleomorphism(18). The origin of this tumour is
controversial as it was initially proposed that the tissue
histiocyte was acting as a facultative fibroblast and that
this explained the apparent bimodal cell population(19).
Indeed, Sohail et al(20) have observed that the diagnosis
of MFH may only be mandatory where immunohisto-
chemical or ultrastructural studies have excluded other
tumours (such as spindle cell squamous carcinoma,
malignant melanoma) that can appear identical on
conventional microscopic examination.
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Of the neoplasms primarily arising from bone tissue,
osteosarcoma (OS) and chondrosarcoma (CHS) were
identified. In this study, most of the osteosarcomas occurred
in the 10 to 30 years age group  (Table 3). This age group
is generally lower than has been reported in other
studies(21). The average age of onset of the tumours of the
jaws and craniofacial bones is 10 to 20 years later than for
skeletal lesions; and the histopathological variables are
more favourable, distant metastases occur less frequently
and survival rates are higher(21-23). Between five and
10% of all osteosarcomas are found in the bones of the
skull, with the majority found in the jaw bones(22). Our
results show that the number of lesions located in the
maxilla and mandible (33%) is consistent with other
reports. Notably, there was a slight preponderance of OS
among males over females in the ratio of 1.3:1.
As would be expected, based on evidence
elsewhere(6), chondrosarcomas were found to have been
particularly rare in this series. Only three lesions had been
diagnosed over the ten-year period. In general, CHS
occurs more often in males, in a ratio of about 2:1; and
there are no pathognomonic signs or symptoms
presented(7). In view of the small number of lesions
identified in the current study, no specific observations
could be made regarding this neoplasm.
It is evident from this investigation that over 70% of
the sarcomas afflicting the neck and craniofacial region
occur earlier than the fourth decade of life. The public needs
with respect to cancer prevention, detection and treatment
should therefore, be of profound interest among health
providers and adminstrators. While prevention closely
relates to the avoidance of known aetiological factors, early
detection of neoplastic change requires not only an efficient
clinical and laboratory medical care system but also one
that is easily accessible and affordable by the public.
Unfortunately, these are tenets that remain grossly
inadequate in many economically underdeveloped societies.
Undoubtedly, current innovations in cancer research
in general are oriented towards the establishment of the
regional pattern of distribution of various neoplastic lesions.
In this way it may be possible to, more precisely, evaluate
the environmental factors that could be associated with the
occurrence of any specific neoplastic lesion. Furthermore,
the ongoing explosive laboratory and clinical investigations
including the biological behaviour patterns of neoplasms
at the molecular and cytogenetic levels may hold key
answers regarding oncogenesis in general. Certainly, the
feasibility of studies such as these may only be
accomplished in prospective protocols where patients are
comprehensively evaluated as they present. However, the
retrospective analysis of existing archival material remains
important since this exercise indeed offers the baseline
information upon which specific prospective analytical
protocols may arise.
Notwithstanding the comparatively small numbers of
sarcomas vis-a-vis other malignancies afflicting the neck
and craniofacial area, their often grave prognosis has to be
of tremendous concern at all times. For the effective
treatment, good histologic differentiation of the primary
tumour is of particular importance. Therefore, the
comprehensive documentation of the numbers of sarcoma
entities that occur globally and the monitoring of their
biological behaviour patterns at presentation and during
treatment needs to be encouraged if future advances in the
effective control of these often lethal neoplasms is to be
realised sooner than later.
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